Omnio Healer AB is a pioneer company in combating inflammatory diseases developing novel drug candidates based on a series of conceptual breakthroughs in inflammation research.
The research founding the basis of Omnio Healer opens up a completely new therapeutic strategy for wound healing and anti-infection management. To reach a rapid clinical proof of concept, otology indications have been selected as the first to enter in the clinical development. Omnio Healer´s main project is currently in late preclinical stage with the aim to enter clinical development late 2010.
Since its foundation in 2006, Omnio Healer has assembled an excellent team of strong management and leadership. This includes experienced world-leading scientists in the research of the new inflammation mechanisms, a management team having solid industry experience from product development and professional investors led by Pergamum AB giving access to a highly qualified network within biotech development. |
|
